Q. What is the news?
A. The Drug Controller General of India (DCGI) granted emergency use approval for pharma major Zydus Cadila’s antiviral drug ‘Virafin’, to treat moderate COVID-19 disease in adults.
Q. What is Virafin?
Q. What are the findings of the clinical trials?
Q. How the drug works?